Valuing IP Ventures: Download the Full Guide
A practical guide to valuing science-driven and IP-rich companies across biotech, medtech, diagnostics, digital health, and deep tech.
We’ve also sent a copy to your inbox so you can review it later. If it doesn’t arrive within a minute, please check your Promotions or Spam folder.
What’s Inside the Guide
A concise, investor-ready overview covering:
-
How valuation works for IP-rich and science-driven companies
-
Why traditional models undershoot value
-
How milestones, optionality, and validation drive valuation
-
What investors look for at different stages
-
Strategic considerations for capital raising, licensing and exit
(Full case studies and methodology included in the PDF.)
Why This Matters
IP-rich companies can hold significant strategic value long before revenue.
To negotiate effectively, raise capital, align stakeholders, or prepare for a transaction, you need a valuation framework that reflects risk, optionality, and commercial reality.
This guide explains how.
About Sherwood Australia
Sherwood Australia is an AFSL-licensed valuation firm specialising in science-driven and technology-based companies across biotech, medtech, diagnostics, digital health, and advanced technology.
We provide independent, defensible valuations for capital raising, licensing, shareholder transactions, and strategic decisions.
Need a Valuation?
We provide fast, professional valuation reports tailored to your needs and sector. Whether you're raising capital, entering a transaction, or simply want clarity on your company’s worth—talk to Sherwood.
Contact Anthony Vago today at anthony@sherwoodaustralia.com.au or +61 406 155 571 for a confidential discussion.
A Proud Member of Sherwood Global Partners
As part of Sherwood Global Partners, we tap into a powerful international network of corporate finance experts, strategic partners, and investors — bringing global opportunity to every transaction.